cytidine monophosphate has been researched along with Leukemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raju, N; Robins, RK; Smee, DF; Vaghefi, MM | 1 |
| Cailla, HL; Carcassonne, Y; Gastaut, JA; Maraninchi, D; Scavennec, J | 1 |
| Harada, M; Isokawa, M; Kimura, F; Kojima, K; Ohmoto, E; Takaba, S; Takeuchi, M; Tanimizu, M | 1 |
| Iwabe, K; Kitazume, K; Okuyama, Y; Urabe, A; Usuki, K | 1 |
| Ealey, KA; Miller, H; Perrino, FW | 1 |
| Higa, T; Kasai, M; Kiyama, Y; Kobayashi, N; Masauzi, N; Naohara, T; Ogasawara, M; Ohizumi, H; Saito, M; Suzuki, G | 1 |
| Harvey, S; Mazur, DJ; Perrino, FW; Ward, H | 1 |
| Brown, KR; Chen, S; Choi, BY; Lin, ZY; Skalski, V | 1 |
| Furukawa, Y; Hiyoshi, M; Im, T; Inoue, K; Kishida, T; Nakao, Y; Ohira, H; Ota, K; Yamane, T; Yasui, Y | 1 |
| Deguchi, K; Kageyama, S; Komada, F; Minami, N; Morita, K; Nishikawa, M; Shirakawa, S; Uemura, Y | 1 |
| Kimura, I; Kimura, K; Masaoka, T; Nakamura, T; Ohno, R; Ohshima, T; Tatsumi, N; Yamada, K | 1 |
| Kamiya, K; Nakamura, T; Sugiyama, M; Tanaka, T; Tsutani, H; Ueda, T; Wano, Y | 1 |
| Grisé-Miron, L; Labonté, L; Leclerc, JM | 1 |
2 trial(s) available for cytidine monophosphate and Leukemia
| Article | Year |
|---|---|
[Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia; Male; Middle Aged | 1996 |
[Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Drug Evaluation; Female; Humans; Japan; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Remission Induction; Vomiting | 1990 |
11 other study(ies) available for cytidine monophosphate and Leukemia
| Article | Year |
|---|---|
Synthesis and biological properties of purine and pyrimidine 5'-deoxy-5'-(dihydroxyphosphinyl)-beta-D-ribofuranosyl analogues of AMP, GMP, IMP, and CMP.
Topics: Adenosine Monophosphate; Animals; Chemical Phenomena; Chemistry; Colonic Neoplasms; Cytidine Monophosphate; Cytosine Nucleotides; Guanine Nucleotides; Guanosine Monophosphate; Humans; Inosine Monophosphate; Inosine Nucleotides; Leukemia; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neoplasms; Phosphorylation; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Tumor Cells, Cultured; Viruses | 1989 |
Purine and pyrimidine ribonucleoside monophosphate patterns of peripheral blood and bone marrow cells in human acute leukemias.
Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Bone Marrow; Cytidine Monophosphate; Erythrocytes; Female; Guanosine Monophosphate; Humans; Leukemia; Male; Middle Aged; Ribonucleotides; Uridine Monophosphate | 1982 |
[Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Topics: Acute Disease; Administration, Oral; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia; Middle Aged | 1995 |
[Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate].
Topics: Administration, Oral; Aged; Arabinonucleotides; Blood Cell Count; Bone Marrow Cells; Cytidine Monophosphate; Humans; Leukemia; Male; Remission Induction | 1994 |
Identification of a 3'-->5'-exonuclease that removes cytosine arabinoside monophosphate from 3' termini of DNA.
Topics: Arabinonucleotides; Base Sequence; Cytidine Monophosphate; Deoxyribonucleotides; DNA Polymerase II; DNA Repair; DNA, Single-Stranded; Exodeoxyribonuclease V; Exodeoxyribonucleases; Hematopoietic Stem Cells; Humans; Leukemia; Molecular Sequence Data; Substrate Specificity | 1994 |
Exonucleases and the incorporation of aranucleotides into DNA.
Topics: Animals; Cattle; Chromatography; Cytarabine; Cytidine Monophosphate; DNA; DNA Polymerase gamma; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Electrophoresis, Polyacrylamide Gel; Exodeoxyribonucleases; HL-60 Cells; Humans; Kinetics; Leukemia; Recombinant Proteins; Thymus Gland; Time Factors; Tissue Inhibitor of Metalloproteinases | 1999 |
A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Cell Nucleus; Cells, Cultured; Cytidine Monophosphate; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Exodeoxyribonuclease V; Exodeoxyribonucleases; Exonucleases; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphocytes; Magnesium; Neoplasm Proteins; Potassium Chloride; Protein Biosynthesis; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation; Vidarabine Phosphate | 2000 |
[Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
Topics: Adult; Aged; Antineoplastic Agents; Arabinonucleotides; Chronic Disease; Cytidine Monophosphate; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Remission Induction | 1991 |
[A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Topics: Acute Disease; Administration, Oral; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukemia; Middle Aged; Prodrugs; Remission Induction | 1990 |
[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms].
Topics: Acute Disease; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Cytosine Nucleotides; Drug Evaluation; Humans; Leukemia; Myelodysplastic Syndromes | 1989 |
Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
Topics: Acute Disease; Arabinonucleotides; Cell Line; Cytidine Monophosphate; Cytosine Nucleotides; Deoxycytidine Monophosphate; DNA Polymerase II; DNA-Binding Proteins; Humans; Leukemia; Leukemia, Myeloid, Acute; Molecular Weight; Uridine Monophosphate | 1987 |